<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00561028</url>
  </required_header>
  <id_info>
    <org_study_id>5105/2001</org_study_id>
    <secondary_id>885/02</secondary_id>
    <nct_id>NCT00561028</nct_id>
  </id_info>
  <brief_title>Chlamydia and Mycoplasma in Coronary Artery Disease</brief_title>
  <official_title>Prevalence of Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Different Forms of Obstructive Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital de Base</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital de Base</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To test the association between anti-Chlamydia serum titers and anti-Mycoplasma antibodies
      with Acute Coronary Syndromes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      One hundred and twenty-six patients were divided into 4 groups: Acute Coronary Syndrome with
      ST-elevation, Non-ST-elevation, stable coronary artery disease, and individuals without
      coronary disease. Anti-Chlamydia and anti-Mycoplasma IgG antibodies were measured at baseline
      and after 6 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2002</start_date>
  <completion_date type="Actual">November 2004</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Test the hypothesis that patients with acute coronary syndromes have higher levels of Chlamydia pneumonia and Mycoplasma pneumonia antibodies in comparison with patients with stable coronary artery disease or controls.</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">138</enrollment>
  <condition>Atherosclerosis</condition>
  <condition>Coronary Artery Disease</condition>
  <condition>Chlamydia Infections</condition>
  <condition>Mycoplasma Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>ST-elevation acute myocardial infarction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>high-risk unstable angina or non-ST-elevation myocardial infarction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>known coronary artery disease, either asymptomatic or with stable angina.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>blood donors without known coronary artery disease.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>blood sample analysis - mycoplasma and chlamydia antibodies</intervention_name>
    <description>Anti-Chlamydia and anti-Mycoplasma IgG antibodies were measured by indirect immunofluorescence at baseline (24 hours of hospitalization) and after 6 months (follow-up).</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood sample - serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1 and 2 - selected after admission in coronary care unit. Group 3 - selected from
        out-patient cardiology clinic. Group 4 - selected from the blood donation unit.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 yrs

          -  Males and females

          -  Agreed to sign the informed consent

        Exclusion Criteria:

          -  Refusal to sign the informed consent

          -  Follow-up not possible

          -  For the &quot;acute&quot; groups, time between the pain beginning and randomization &gt;24 hours

          -  Active infections

          -  Use of antimicrobial agents within the last 30 days

          -  End-stage diseases with life expectancy &lt;6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jose C Nicolau, MD, pHD</last_name>
    <role>Study Director</role>
    <affiliation>University of Sao Paulo</affiliation>
  </overall_official>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 19, 2007</study_first_submitted>
  <study_first_submitted_qc>November 19, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2007</study_first_posted>
  <last_update_submitted>November 19, 2007</last_update_submitted>
  <last_update_submitted_qc>November 19, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 20, 2007</last_update_posted>
  <keyword>Atherosclerosis</keyword>
  <keyword>Coronary artery disease</keyword>
  <keyword>Chlamydia pneumoniae</keyword>
  <keyword>Mycoplasma pneumoniae</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Chlamydia Infections</mesh_term>
    <mesh_term>Pleuropneumonia</mesh_term>
    <mesh_term>Mycoplasma Infections</mesh_term>
    <mesh_term>Pneumonia, Mycoplasma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Antibodies</mesh_term>
    <mesh_term>Immunoglobulins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

